NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
Frequently asked questions
What sector does NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) operate in?
NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) belongs to the Other sector and operates in the Health Information Services industry.
What is NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) current stock price?
As of the latest data, NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) stock price is CA$0.92, with a previous close of CA$0.92.
What is NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) current market capitalization?
NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) market cap is approximately 84.46 million.
What is NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.07.
Does NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) pay dividends?
No. NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) does not pay a dividend.
What is NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) (AIAI) beta (volatility) score?
NetraMark Holdings Inc. (formerly was MEND/Nurosene Health Inc. until 2023-01-31) has a beta of 1.590, suggesting it is more volatile than the market.